Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA

Farallon Capital Management, L.L.C. reported a 8.30% stake in Enanta Pharmaceuticals, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Farallon Capital Management, L.L.C. reported a 8.30% stake in Enanta Pharmaceuticals, Inc., 2,418,202 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
8.30%
Shares
2,418,202
Intent
Passive
What changed
Stake changed
Filed together
27 holders

The filing in full

HolderStakeShares
Farallon Capital Management, L.L.C.8.30%2,418,202
Farallon Capital Partners, L.P.0%0
Farallon Capital Institutional Partners, L.P.0%0
Farallon Capital Institutional Partners II, L.P.0%0
Farallon Capital Institutional Partners III, L.P.0%0
Four Crossings Institutional Partners V, L.P.0%0
Farallon Capital Offshore Investors II, L.P.0%0
Farallon Capital (AM) Investors, L.P.0%0
Farallon Capital F5 Master I, L.P.0%0
Farallon Partners, L.L.C.0%0
Farallon Institutional (GP) V, L.L.C.0%0
Farallon F5 (GP), L.L.C.0%0
Dapice Joshua J.8.30%2,418,202
Dreyfuss, Philip D.8.30%2,418,202
Dunn Hannah E.8.30%2,418,202
Gehani, Varun N.8.30%2,418,202
Giauque, Nicolas8.30%2,418,202
Husen, Avner A.8.30%2,418,202
Kim, David T.8.30%2,418,202
Linn, Michael G.8.30%2,418,202
Luo Patrick (Cheng)8.30%2,418,202
Roberts, Jr., Thomas G.8.30%2,418,202
Saito Edric C.8.30%2,418,202
Short Daniel S.8.30%2,418,202
Spokes, Andrew J. M.8.30%2,418,202
Warren, John R.8.30%2,418,202
Wehrly, Mark C.8.30%2,418,202

Source

View original at SEC

Related